Phrontline Biopharma

Developer of therapeutics for various diseases

placePudong, Shanghai, China calendar_todayFounded 2022 language phrontlinebio.com

Innovation

2 patent families — focus: Human necessities; filing pace active. Cited 33 times.

YearFilings
20241
20252
20261

Investor mix

10 investors on record; lead investors include Lapam Capital.

Investor typeCountShare
Venture capital550%
Other / undisclosed550%
Coming soon